These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 18257437

  • 21. Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study.
    Kallen AJ, Jhung MA, Cheng S, Hess T, Turabelidze G, Abramova L, Arduino M, Guarner J, Pollack B, Saab G, Patel PR.
    Am J Kidney Dis; 2008 Jun; 51(6):966-75. PubMed ID: 18501784
    [Abstract] [Full Text] [Related]

  • 22. Nephrogenic systemic fibrosis: a serious iatrogenic disease of renal failure patients.
    Khurram M, Skov L, Rossen K, Thomsen HS, Marckmann P.
    Scand J Urol Nephrol; 2007 Jun; 41(6):565-6. PubMed ID: 17934986
    [Abstract] [Full Text] [Related]

  • 23. Gadolinium-associated nephrogenic systemic fibrosis.
    Schlaudecker JD, Bernheisel CR.
    Am Fam Physician; 2009 Oct 01; 80(7):711-4. PubMed ID: 19817341
    [Abstract] [Full Text] [Related]

  • 24. An epidemic outbreak of nephrogenic systemic fibrosis in a Danish hospital.
    Marckmann P.
    Eur J Radiol; 2008 May 01; 66(2):187-90. PubMed ID: 18328659
    [Abstract] [Full Text] [Related]

  • 25. Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction.
    Kay J.
    Ann Rheum Dis; 2008 Dec 01; 67 Suppl 3():iii66-9. PubMed ID: 19022818
    [Abstract] [Full Text] [Related]

  • 26. Gadolinium-based contrast media and the development of nephrogenic systemic fibrosis in patients with renal insufficiency.
    Chewning RH, Murphy KJ.
    J Vasc Interv Radiol; 2007 Mar 01; 18(3):331-3. PubMed ID: 17377176
    [Abstract] [Full Text] [Related]

  • 27. Nephrogenic systemic fibrosis: is gadolinium the missing piece to the puzzle?
    Bennett LK, Garrett AL.
    Cutis; 2008 May 01; 81(5):421-6. PubMed ID: 18543594
    [Abstract] [Full Text] [Related]

  • 28. Nephrogenic systemic fibrosis: a population study examining the relationship of disease development to gadolinium exposure.
    Deo A, Fogel M, Cowper SE.
    Clin J Am Soc Nephrol; 2007 Mar 01; 2(2):264-7. PubMed ID: 17699423
    [Abstract] [Full Text] [Related]

  • 29. Nephrogenic systemic fibrosis: center case review.
    Lauenstein TC, Salman K, Morreira R, Tata S, Tudorascu D, Baramidze G, Singh-Parker S, Martin DR.
    J Magn Reson Imaging; 2007 Nov 01; 26(5):1198-203. PubMed ID: 17969162
    [Abstract] [Full Text] [Related]

  • 30. Gadolinium-associated nephrogenic systemic fibrosis: the need for nephrologists' awareness.
    Canavese C, Mereu MC, Aime S, Lazzarich E, Fenoglio R, Quaglia M, Stratta P.
    J Nephrol; 2008 Nov 01; 21(3):324-36. PubMed ID: 18587720
    [Abstract] [Full Text] [Related]

  • 31. Gadolinium-containing MRI contrast agents: important variations on a theme for NSF.
    Kuo PH.
    J Am Coll Radiol; 2008 Jan 01; 5(1):29-35. PubMed ID: 18180006
    [Abstract] [Full Text] [Related]

  • 32. [Nephrogenic systemic fibrosis--a new interdisciplinary challenge].
    Witzke O, Hillen U, Barkhausen J, Daul A, Kribben A.
    Dtsch Med Wochenschr; 2007 Dec 01; 132(50):2706-10. PubMed ID: 18058663
    [Abstract] [Full Text] [Related]

  • 33. Nephrogenic systemic fibrosis: a case series suggesting gadolinium as a possible aetiological factor.
    Moreno-Romero JA, Segura S, Mascaró JM, Cowper SE, Julià M, Poch E, Botey A, Herrero C.
    Br J Dermatol; 2007 Oct 01; 157(4):783-7. PubMed ID: 17627792
    [Abstract] [Full Text] [Related]

  • 34. Clinical and histological findings in nephrogenic systemic fibrosis.
    Cowper SE, Rabach M, Girardi M.
    Eur J Radiol; 2008 May 01; 66(2):191-9. PubMed ID: 18325705
    [Abstract] [Full Text] [Related]

  • 35. Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis.
    High WA, Ayers RA, Chandler J, Zito G, Cowper SE.
    J Am Acad Dermatol; 2007 Jan 01; 56(1):21-6. PubMed ID: 17097388
    [Abstract] [Full Text] [Related]

  • 36. The impact of NSF on the care of patients with kidney disease.
    Abu-Alfa A.
    J Am Coll Radiol; 2008 Jan 01; 5(1):45-52. PubMed ID: 18180009
    [Abstract] [Full Text] [Related]

  • 37. Gadolinium use in patients with kidney disease: a cause for concern.
    Perazella MA, Rodby RA.
    Semin Dial; 2007 Jan 01; 20(3):179-85. PubMed ID: 17555477
    [Abstract] [Full Text] [Related]

  • 38. [Nephrogenic systemic fibrosis--new clinical entity].
    Prvulović M.
    Med Pregl; 2008 Jan 01; 61(9-10):439-41. PubMed ID: 19203058
    [Abstract] [Full Text] [Related]

  • 39. Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure.
    Othersen JB, Maize JC, Woolson RF, Budisavljevic MN.
    Nephrol Dial Transplant; 2007 Nov 01; 22(11):3179-85. PubMed ID: 17890246
    [Abstract] [Full Text] [Related]

  • 40. Circulating fibrocytes: cellular basis for NSF.
    Bucala R.
    J Am Coll Radiol; 2008 Jan 01; 5(1):36-9. PubMed ID: 18180007
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.